Lexicon Pharmaceuticals
LXRX
#7133
Rank
HK$4.95 B
Marketcap
HK$11.14
Share price
-4.05%
Change (1 day)
6.99%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -HK$1.17

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$1.18. In 2025 the company made an earnings per share (EPS) of -HK$1.10 an increase over its 2024 EPS that were of -HK$5.02.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.176.67%
2025-HK$1.10-78.13%
2024-HK$5.02-20%
2023-HK$6.2831.15%
2022-HK$4.78-0%
2021-HK$4.7810.91%
2020-HK$4.31-145.08%
2019HK$9.57-206.09%
2018-HK$9.02-5.74%
2017-HK$9.57-10.95%
2016-HK$10.752640%
2015-HK$0.39-96.34%
2014-HK$10.70-2.53%
2013-HK$10.98-9.09%
2012-HK$12.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$146.06-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$42.44-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$328.75-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$45.81 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$78.52-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.16-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.88 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$2.98-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$229.76 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA